Relevant bibliographies by topics / Dithranol ; Psoriasis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Book chapters

Academic literature on the topic 'Dithranol ; Psoriasis'

Author: Grafiati
Published: 4 June 2021
Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dithranol ; Psoriasis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dithranol ; Psoriasis"

1

C, Anahera, and Kahurangi S. "Development of Dithranol overloaded hard Lipid Nanoparticles." International Journal of Pharmacy and Biomedical Engineering 2, no. 3 (2015): 5–8. http://dx.doi.org/10.14445/23942576/ijpbe-v2i3p102.

Full text
Abstract:
Dithranol belongs to the keratolytic category, which is widely used drug in the treatment of psoriasis. The drug is virtually inexplicable in water. Many conservative quantity forms for psoriasis treatment have been have been formulated earlier, but they did not show good results. Hence in the present study, it was attempted to invent dithranol in the form of solid lipid nanoparticle. Solid lipid nanoparticles of dithranol were obtained by alteration of lipid spreading method. Preformulation studies were performed to check the compatibility of drug and excepient for the development of formulat
APA, Harvard, Vancouver, ISO, and other styles
2

Prins, M., O. Q. J. Swinkels, J. M. Mommers, M. J. P. Gerritsen, and P. G. M. Valk. "Dithranol treatment of psoriasis in dithranol-sensitive patients." Contact Dermatitis 41, no. 2 (2007): 116–17. http://dx.doi.org/10.1111/j.1600-0536.1999.tb06250.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

SEVILLE, R. H. "Simplified dithranol treatment for psoriasis*." British Journal of Dermatology 93, no. 2 (2006): 205–8. http://dx.doi.org/10.1111/j.1365-2133.1975.tb06742.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Haas, Norbert, Andrea Wulff-Woesten, Wolfram Sterry, and Hans Meffert. "Die Behandlung der Psoriasis capillitii mit Dithranol. Dithranol in the treatment of scalp psoriasis." Journal der Deutschen Dermatologischen Gesellschaft 1, no. 9 (2003): 688–93. http://dx.doi.org/10.1046/j.1610-0387.2003.03029.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Young, E. "Treatment of Psoriasis with Dithranol Cream Compared with Dithranol Paste." Dermatology 173, no. 6 (1986): 285–87. http://dx.doi.org/10.1159/000249272.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lowe, N. J. "Phototherapy and dithranol treatment of psoriasis." BMJ 294, no. 6575 (1987): 839. http://dx.doi.org/10.1136/bmj.294.6575.839.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mok, Chong-Fai, Chuan-Ming Xie, Kathy Wai-Yan Sham, Zhi-Xiu Lin, and Christopher Hon-Ki Cheng. "1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–19. http://dx.doi.org/10.1155/2013/792840.

Full text
Abstract:
Psoriasis, which affects approximately 1–3% of the population worldwide, is a chronic inflammatory skin disorder characterized by epidermal keratinocytes hyperproliferation, abnormal differentiation, and inflammatory infiltration. Decrease in keratinocyte apoptosis is a specific pathogenic phenomenon in psoriasis. Chinese herbs have been used for the treatment of psoriasis in China showing promising effect in clinical trials. A traditional Chinese medicine has relatively fewer side effects with longer remission time and lower recurrence rate. The extract ofRubia cordifoliaL. (EA) was previousl
APA, Harvard, Vancouver, ISO, and other styles
8

Prins, M., Qoj Swinkels, B. Bertholet, and P. GM van der Valk. "Dithranol short-contact treatment of scalp psoriasis." Journal of Dermatological Treatment 10, no. 1 (1999): 13–17. http://dx.doi.org/10.3109/09546639909055905.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hollywood, Katherine A., Catherine L. Winder, Warwick B. Dunn, et al. "Exploring the mode of action of dithranol therapy for psoriasis: a metabolomic analysis using HaCaT cells." Molecular BioSystems 11, no. 8 (2015): 2198–209. http://dx.doi.org/10.1039/c4mb00739e.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Cost effectiveness of calcipotriol vs dithranol for psoriasis." Inpharma Weekly &NA;, no. 978 (1995): 7. http://dx.doi.org/10.2165/00128413-199509780-00012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Dithranol ; Psoriasis"

1

Lubwika, Paul. "A stability study of dithranol in solution, formulations and in normal and psoriatic skin." Thesis, Robert Gordon University, 1994. http://hdl.handle.net/10059/2348.

Full text
Abstract:
For more than 100 years dithranol has been successfully used for the treatment of psoriasis . It is still not fully understood, however, how it exerts its antipsoriatic effect. From the information available to date it is clear that the actual process of decomposition is central to the therapeutic action of dithranol. Since there is an obvious parallel between the mechanism of decomposition in solution and that of decomposition/metabolism in skin stability studies were carried out in aqueous buffer (PH 5.5). The effect of various factors such as the presence of various metal ions and surfactan
APA, Harvard, Vancouver, ISO, and other styles
2

Priprem, Aroonsri. "The development and evaluation of a hydrogel drug delivery system for dithranol." Thesis, Robert Gordon University, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.278936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Savian, Ana Luiza. "DESENVOLVIMENTO DE NANOCÁPSULAS CONTENDO DITRANOL E SUA INCORPORAÇÃO EM FORMULAÇÃO SEMISSÓLIDA DE BASE AQUOSA." Universidade Federal de Santa Maria, 2012. http://repositorio.ufsm.br/handle/1/5979.

Full text
Abstract:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior<br>Dithranol is very effective drug for the topical treatment of psoriasis. However, it has some adverse effects, such as irritation and stain in the skin that difficult its application and patient adherence to treatment. Its instability to light, high pH values, metals and the presence of oxygen, configure as a limiting step for use. So, the inclusion of drug in nanocarriers was the main objective of this work. Lipid core nanocapsules and nanoemulsions containing 0.5 mg/mL of dithranol and 0.05% of EDTA or 0.02% of ascorbic acid were
APA, Harvard, Vancouver, ISO, and other styles
4

Milner, Sarah Elizabeth. "The effects of the anti-psoriatic agent dithranol on intracellular calcium signalling in keratinocytes." Thesis, University of Newcastle Upon Tyne, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501057.

Full text
Abstract:
Psoriasis is a common chronic inflammatory disease of the skin and affects 2 % of the Western population. It is characterised by increased keratinocyte proliferation, abnormal keratinocyte differentiation and an infiltration of lymphocytes and neutrophils but to date the aetiology of psoriasis remains incompletely understood. Several lines of evidence indicate a fundamental defect in calcium signalling in keratinocytes. Previous research has shown that keratinocytes cultured from uninvolved psoriatic skin show enhanced cellular calcium responses to calcium-mobilising agonists. The presence of
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Dithranol ; Psoriasis"

1

Mustakallio, K. K. "Treatment of Psoriasis with Dithranol (Cignolin, Anthralin) and Other Hydroxyanthrones." In Dermatology in Five Continents. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83360-1_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Przybilla, B., P. Kaudewitz, and K. Bieber. "Harnstoff in Kombination mit Dithranol zur Therapie der Psoriasis vulgaris." In Harnstoff in der Dermatologie. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83754-8_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Dithranol ; Psoriasis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography